Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

February 29, 2016

Conditions
Leiomyoma
Interventions
DRUG

TSD

"TSD is composed of 15 individual Chinese medicines: Astragalus Membranaceus, Semen Coicis, Poria, Curcuma longa L, and Fritillaria Thunbergii Miq, Cassia twig, Pollen typhae, Resina draconis, Lithospermum erythrorhizon, Halloysitum Rubrum, Rhizoma Corydalis processed with vinegar, Hirudo, Calcined corrugated sub , Oyster Shell and Laminaria Japonica Aresch.~High dose (127g) or Low dose (69g) TSD decoction boiled as 200ml per bag; 2 bags per day, 6 days per week; Orally in-take one bag of TSD decoction in morning and another in evening after meal; The whole treatment lasts for 16 weeks."

Trial Locations (1)

852

School of Chinese Medicine, University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02189083 - Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids | Biotech Hunter | Biotech Hunter